Predictors of EGFR mutation and factors associated with clinical tumor stage at diagnosis: Experience of the INSIGHT study in Poland

Targeted therapy of non-small cell lung cancer (NSCLC) patients with mutations in the epidermal growth factor receptor (EGFR) gene has been associated with improved prognosis. However, there is a shortage on data from real-world clinical practice in management of EGFR-positive NSCLC patients in Pola...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Ramlau, Rodryg, Krawczyk, Paweł, Dziadziuszko, Rafał, Chmielewska, Izabela, Milanowski, Janusz, Olszewski, Włodzimierz, Stencel, Katarzyna, Ramlau-Piątek, Katarzyna, Segiet, Agnieszka, Skroński, Michał, Grudny, Jacek, Chorostowska-Wynimko, Joanna
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5656037/
https://ncbi.nlm.nih.gov/pubmed/29113190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6907
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados